Description

Description

Clenil Compostium For Aerosol is a prescription combination respiratory medicine manufactured by Chiesi Pharmaceuticals, containing both Beclomethasone and Salbutamol as its active ingredients. This combination brings together two complementary mechanisms of action within a single nebuliser solution: Beclomethasone, an inhaled corticosteroid that works to reduce airway inflammation over time, and Salbutamol, a short-acting beta-2 agonist bronchodilator that works quickly to relax the muscles around the airways, providing more immediate relief from airway constriction. By combining an anti-inflammatory agent with a fast-acting bronchodilator in one formulation, Clenil Compostium is designed to address both the underlying inflammation and the immediate symptoms of airway narrowing in a single nebulization session. Each pack contains 10 single-use ampoules intended for administration via a nebulizer device, offering a convenient supply for patients whose respiratory treatment plan calls for this combined approach, as determined by their physician.

Ingredients

Each Clenil Compostium ampoule contains a combination of Beclomethasone and Salbutamol formulated as a sterile suspension or solution intended specifically for nebulization. The exact strength of each active ingredient per ampoule should be confirmed on the product packaging, as combination formulations can vary by presentation and market. The formulation also includes pharmaceutical-grade inactive components that help maintain the sterility, stability, and consistency of the solution, ensuring it performs reliably when converted into an inhalable mist by the nebulizer.

Dosage Form

Clenil Compostium For Aerosol is supplied as a nebuliser suspension or solution in single-use ampoules, intended for use with a nebulizer machine. Each ampoule is designed for one treatment session and should not be reused, helping to maintain sterility and ensure an accurate combined dose of both active ingredients with each use.

Uses

Clenil Compostium For Aerosol is used in the management of respiratory conditions where both airway inflammation and airway constriction are contributing to symptoms, such as asthma and certain presentations of chronic obstructive pulmonary disease (COPD). The corticosteroid component helps reduce ongoing airway inflammation, supporting better long-term symptom control, while the bronchodilator component provides more immediate relief from wheezing, chest tightness, and shortness of breath during a nebulization session. This combined approach may be used for patients who require both types of therapy together, particularly during periods of increased symptom activity, based on a physician’s assessment of the individual’s respiratory condition.

How to Use

Clenil Compostium should be used strictly according to a physician’s instructions and administered using a properly functioning, clean nebulizer device. Each ampoule is generally opened immediately before use and its contents added directly to the nebulizer chamber. The patient then inhales the resulting mist through a mouthpiece or face mask over several minutes until the solution is fully nebulized. After each session, rinsing the mouth with water is generally recommended to help reduce the risk of oral side effects associated with the inhaled corticosteroid component, such as throat irritation or oral thrush. The frequency and timing of use should strictly follow the schedule set by the prescribing physician, and patients should not increase the frequency of use on their own, even if symptoms feel poorly controlled, without first consulting their doctor.

Side Effects

Side effects of Clenil Compostium may reflect the combined profile of both active ingredients. From the corticosteroid component, patients may experience throat irritation, hoarseness, dry cough, oral thrush, or an unpleasant taste, particularly if the mouth is not rinsed after use. From the bronchodilator component, common effects may include a fast or pounding heartbeat, hand tremor, headache, nervousness, or muscle cramps, especially with more frequent use. Some patients may also notice mild dizziness or throat dryness. With long-term or frequent use, closer monitoring by a physician is important to ensure the treatment remains appropriately balanced and effective. Allergic reactions, though uncommon, may present as skin rash, swelling, or difficulty breathing and require immediate medical attention. Any new, worsening, or persistent symptoms should be discussed with a healthcare provider promptly.

Pregnancy & Breastfeeding

The use of Clenil Compostium during pregnancy should be carefully evaluated by a physician, as both inhaled corticosteroids and short-acting bronchodilators are sometimes continued during pregnancy when respiratory symptoms need to be controlled, since poorly managed asthma or airway disease can itself pose risks to both mother and baby. Small amounts of these medications may pass into breast milk, so their use while breastfeeding should also be guided by a doctor’s assessment of the individual situation. Pregnant or breastfeeding individuals should inform their physician of their status before starting or continuing this combination treatment.

Storage Instructions

Store Clenil Compostium ampoules at room temperature, protected from direct sunlight, excessive heat, and moisture. Keep ampoules in their original packaging until ready for use, and use each ampoule immediately after opening, discarding any unused portion rather than storing it for later use. Store out of reach of children and pets. Do not use ampoules beyond their printed expiry date, and dispose of used or expired ampoules according to local pharmaceutical or medical waste disposal guidelines rather than regular household trash.

FAQs

Why does this product combine two different active ingredients?
Combining an anti-inflammatory corticosteroid with a fast-acting bronchodilator allows a single nebulization session to address both the underlying airway inflammation and immediate airway constriction together, as determined appropriate by a physician.

Can this be used as a rescue treatment during a sudden breathing difficulty episode?
The bronchodilator component can provide relatively quick relief, but the overall product is generally used as part of a structured treatment plan set by a doctor rather than as a self-directed emergency rescue option.

Is it normal to notice hand tremors or a faster heartbeat after use?
Mild tremor or a temporary increase in heart rate can occur due to the bronchodilator component and are generally recognized effects, but symptoms that are severe or persistent should be reported to a doctor.

Should the mouth be rinsed after every session, or only sometimes?
Rinsing the mouth after each session is generally recommended to help minimize the risk of oral thrush and throat irritation associated with the corticosteroid component.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.